Literature DB >> 33728212

Isolated Encephalopathy Without Severe Disease in a COVID-19 Patient: Case Presentation and Workup Strategies.

Lindsay S McAlpine1, Mary Barden1, Adeel S Zubair1, Sirisha Sanamandra1.   

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the virus responsible for the human coronavirus disease 2019 (COVID-19). It has been shown to cause not only respiratory disease but has manifestation in multiple organ systems. Encephalopathy has been shown to be associated with COVID-19; typically, it presents with other findings of the disease including headache, respiratory dysfunction, and fevers. We report a case of a 60-year-old man with hypertension who presented with confusion and cognitive decline concerning for encephalopathy and was found to have COVID-19. On neurologic examination, he had impaired episodic memory, attention, and comprehension with intact motor and sensory examination. Other than fatigue, the patient had no other common COVID-19 symptoms.
Copyright © 2021, McAlpine et al.

Entities:  

Keywords:  confusion; coronavirus; covid-19; encephalopathy

Year:  2021        PMID: 33728212      PMCID: PMC7955529          DOI: 10.7759/cureus.13277

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  15 in total

1.  COVID-19-associated acute disseminated encephalomyelitis (ADEM).

Authors:  Timothy Parsons; Sarah Banks; Chay Bae; Joel Gelber; Hussein Alahmadi; Matthew Tichauer
Journal:  J Neurol       Date:  2020-05-30       Impact factor: 4.849

2.  The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).

Authors:  Mervyn Singer; Clifford S Deutschman; Christopher Warren Seymour; Manu Shankar-Hari; Djillali Annane; Michael Bauer; Rinaldo Bellomo; Gordon R Bernard; Jean-Daniel Chiche; Craig M Coopersmith; Richard S Hotchkiss; Mitchell M Levy; John C Marshall; Greg S Martin; Steven M Opal; Gordon D Rubenfeld; Tom van der Poll; Jean-Louis Vincent; Derek C Angus
Journal:  JAMA       Date:  2016-02-23       Impact factor: 56.272

3.  Prognostic Value of C-Reactive Protein in Patients With Coronavirus 2019.

Authors:  Xiaomin Luo; Wei Zhou; Xiaojie Yan; Tangxi Guo; Benchao Wang; Hongxia Xia; Lu Ye; Jun Xiong; Zongping Jiang; Yu Liu; Bicheng Zhang; Weize Yang
Journal:  Clin Infect Dis       Date:  2020-11-19       Impact factor: 9.079

Review 4.  Septic encephalopathy.

Authors:  Marek Ziaja
Journal:  Curr Neurol Neurosci Rep       Date:  2013-10       Impact factor: 5.081

5.  Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study.

Authors:  Aravinthan Varatharaj; Naomi Thomas; Mark A Ellul; Nicholas W S Davies; Thomas A Pollak; Elizabeth L Tenorio; Mustafa Sultan; Ava Easton; Gerome Breen; Michael Zandi; Jonathan P Coles; Hadi Manji; Rustam Al-Shahi Salman; David K Menon; Timothy R Nicholson; Laura A Benjamin; Alan Carson; Craig Smith; Martin R Turner; Tom Solomon; Rachel Kneen; Sarah L Pett; Ian Galea; Rhys H Thomas; Benedict D Michael
Journal:  Lancet Psychiatry       Date:  2020-06-25       Impact factor: 27.083

6.  Neuropathology of COVID-19: a spectrum of vascular and acute disseminated encephalomyelitis (ADEM)-like pathology.

Authors:  R Ross Reichard; Kianoush B Kashani; Nicholas A Boire; Eleni Constantopoulos; Yong Guo; Claudia F Lucchinetti
Journal:  Acta Neuropathol       Date:  2020-05-24       Impact factor: 17.088

7.  Neuropathological Features of Covid-19.

Authors:  Isaac H Solomon; Erica Normandin; Shamik Bhattacharyya; Shibani S Mukerji; Kiana Keller; Ahya S Ali; Gordon Adams; Jason L Hornick; Robert F Padera; Pardis Sabeti
Journal:  N Engl J Med       Date:  2020-06-12       Impact factor: 91.245

8.  EEG findings in COVID-19 related encephalopathy.

Authors:  Elena Pasini; Francesca Bisulli; Lilia Volpi; Irene Minardi; Maria Tappatà; Lorenzo Muccioli; Umberto Pensato; Patrizia Riguzzi; Paolo Tinuper; Roberto Michelucci
Journal:  Clin Neurophysiol       Date:  2020-07-18       Impact factor: 3.708

9.  Neurologic Features in Severe SARS-CoV-2 Infection.

Authors:  Julie Helms; Stéphane Kremer; Hamid Merdji; Raphaël Clere-Jehl; Malika Schenck; Christine Kummerlen; Olivier Collange; Clotilde Boulay; Samira Fafi-Kremer; Mickaël Ohana; Mathieu Anheim; Ferhat Meziani
Journal:  N Engl J Med       Date:  2020-04-15       Impact factor: 91.245

10.  Acute disseminated encephalomyelitis after SARS-CoV-2 infection.

Authors:  Giovanni Novi; Tommaso Rossi; Enrico Pedemonte; Laura Saitta; Claudia Rolla; Luca Roccatagliata; Matilde Inglese; Daniele Farinini
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2020-06-01
View more
  1 in total

Review 1.  Immune-mediated neurological syndrome in SARS-CoV-2 infection: a review of literature on autoimmune encephalitis in COVID-19.

Authors:  Alvin Oliver Payus; Mohammad Saffree Jeffree; May Honey Ohn; Hui Jan Tan; Azliza Ibrahim; Yuen Kang Chia; Azman Ali Raymond
Journal:  Neurol Sci       Date:  2021-12-01       Impact factor: 3.830

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.